Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT/PDT therapy and optical bioimaging.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Uptake and Retention of Laser-synthesized Boron Nanoparticles in Tumor Cells and Fibroblasts.

Doklady. Biochemistry and biophysics·2026
Same author

The effect of dimeric bisbenzimidazoles on the activity of DNA repair enzymes TDP1, TDP2, PARP1 and PARP2.

Vavilovskii zhurnal genetiki i selektsii·2026
Same author

Synthesis and Pharmacokinetics of Nanosized NH<sub>2</sub>‑UiO‑66 (Zr) Metal-Organic Frameworks.

Doklady. Biochemistry and biophysics·2026
Same author

Targeted Radionuclide Detection of Malignant Tumors Using Affibody.

Acta naturae·2026
Same author

Targeted Nanoliposomes for the Delivery of Boronophenylalanine into HER2-Positive Cells.

Acta naturae·2025
Same journal

The Microbiomic Metaproteome of the Taiga Tick Ixodes persulcatus from the Tyumen Region.

Acta naturae·2026
Same journal

The Distribution and Genetic Variability of Potato Viruses in Russian Regions.

Acta naturae·2026
Same journal

Stabilization of Transaminases in Aqueous-Organic Media by Pyridoxal-5'-phosphate: A Case Study of Transaminase from Desulfomonile tiedjei.

Acta naturae·2026
Same journal

Novel Nicotinic Acetylcholine Receptor Inhibitors Derived from Oleoylcholine Analogs.

Acta naturae·2026
Same journal

Identifying microRNA Expression Alterations in Erythrocytes, Lymphocytes, and Monocytes During Severe COVID-19.

Acta naturae·2026
Same journal

Cellular Type Is a Major Determinant of R-Loop Genomic Distribution.

Acta naturae·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.9K

Bioreactor-Based Tumor Tissue Engineering.

A E Guller1, P N Grebenyuk2, A B Shekhter3

  • 1Macquarie University, Sydney, 2109, New South Wales, Australia ; ARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney 2109, New South Wales, Australia ; Sechenov First Moscow State Medical University, Institute for Regenerative Medicine, 8, Trubetskaya Str., Moscow, 119992, Russia ; Lobachevsky Nizhniy Novgorod State University, 23, Gagarina Ave., Nizhniy Novgorod, 603950, Russia.

Acta Naturae
|November 1, 2016
PubMed
Summary
This summary is machine-generated.

Tumor tissue engineering (TTE) creates 3D cancer models using tissue engineering constructs (TECs). Bioreactor technology is crucial for maintaining these in vitro tumor models for research and therapeutic development.

Keywords:
bioreactorscancermodelstissue engineering

More Related Videos

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

10.2K
Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks
06:07

Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks

Published on: November 2, 2020

5.5K

Related Experiment Videos

Last Updated: Mar 12, 2026

Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.9K
Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

10.2K
Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks
06:07

Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks

Published on: November 2, 2020

5.5K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Regenerative Medicine

Background:

  • Cancer research traditionally relies on 2D cultures or animal models, which have limitations in mimicking the complex tumor microenvironment.
  • Tumor tissue engineering (TTE) offers a novel approach to create more physiologically relevant 3D cancer models.
  • Developing advanced in vitro models is essential for understanding cancer biology and accelerating drug discovery.

Purpose of the Study:

  • To review the current state and emerging applications of bioreactor technology in tumor tissue engineering (TTE).
  • To highlight the design and development of complex tissue engineering constructs (TECs) for simulating malignant neoplasms.
  • To discuss the role of bioreactors in optimizing culture conditions and controlling the development of in vitro tumor models.

Main Methods:

  • Analysis of popular bioreactor types utilized in TTE.
  • Review of the components of tissue engineering constructs (TECs), including cancer cells, scaffolds, and tumor microenvironment elements.
  • Discussion of the in vitro maintenance and properties of engineered tumor models.

Main Results:

  • Bioreactor technology is identified as a key enabler for successful TTE, facilitating realistic simulation and long-term maintenance of tumor properties.
  • Various bioreactor types are evaluated for their suitability in supporting the development and function of tumor TECs.
  • Emerging applications of TTE in cancer research, diagnosis, and treatment development are explored.

Conclusions:

  • TTE, supported by advanced bioreactor systems, provides a powerful platform for in vitro cancer modeling.
  • This technology holds significant promise for advancing cancer biology research and facilitating the development of novel cancer therapies.
  • Optimized bioreactor-based TTE can lead to more accurate preclinical testing of diagnostic and therapeutic strategies.